SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,353,491 | +9.6% | 303,339 | -0.6% | 0.02% | +10.5% |
| Q2 2023 | $58,737,724 | -4.7% | 305,201 | +0.3% | 0.02% | -9.5% |
| Q1 2023 | $61,625,204 | +159068.3% | 304,363 | +1.0% | 0.02% | +90.9% |
| Q4 2022 | $38,717 | -99.9% | 301,278 | +0.3% | 0.01% | -31.2% |
| Q3 2022 | $41,112,000 | -22.5% | 300,467 | +0.2% | 0.02% | -15.8% |
| Q2 2022 | $53,079,000 | +23.4% | 299,967 | +0.4% | 0.02% | +46.2% |
| Q1 2022 | $43,025,000 | -1.3% | 298,711 | +5.9% | 0.01% | 0.0% |
| Q4 2021 | $43,596,000 | -5.9% | 281,962 | +3.3% | 0.01% | -13.3% |
| Q3 2021 | $46,354,000 | +10.1% | 273,065 | +2.4% | 0.02% | +15.4% |
| Q2 2021 | $42,100,000 | +14.6% | 266,651 | +1.0% | 0.01% | +8.3% |
| Q1 2021 | $36,727,000 | -19.7% | 264,135 | +1.2% | 0.01% | -29.4% |
| Q4 2020 | $45,738,000 | – | 261,057 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |